These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22129872)

  • 1. [Current situation and measures to promote anti-doping activities in Japan].
    Asakawa S
    Yakugaku Zasshi; 2011; 131(12):1755-6. PubMed ID: 22129872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clarification of the Relationship between Awareness of Doping of Competitive Sports Coaches and Their Instructions to Prevent Doping].
    Yamaguchi T; Horio I; Goto M; Miyauchi Y; Izushi F
    Yakugaku Zasshi; 2016; 136(8):1185-93. PubMed ID: 27477736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-doping reference for pharmacists].
    Kasashi K
    Yakugaku Zasshi; 2009 Dec; 129(12):1475-81. PubMed ID: 19952525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. True Dopers or Negligent Athletes? An Analysis of Anti-Doping Rule Violations Reported to the World Anti-Doping Agency 2010-2012.
    de Hon O; van Bottenburg M
    Subst Use Misuse; 2017 Dec; 52(14):1932-1936. PubMed ID: 28742405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current Status of Doping in Japan Based on Japan Anti-Doping Disciplinary Panels of the Japan Anti-Doping Agency (JADA): A Suggestion on Anti-Doping Activities by Pharmacists in Japan].
    Imanishi T; Kawabata T; Takayama A
    Yakugaku Zasshi; 2017; 137(7):883-891. PubMed ID: 28674304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of the role of the sports pharmacist with a model for the prediction of athletes' actions to cope with sickness].
    Yamaguchi T; Horio I; Aoki R; Yamashita N; Tanaka M; Izushi F; Miyauchi Y; Araki H
    Yakugaku Zasshi; 2013; 133(11):1249-59. PubMed ID: 24189566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge of pharmacy students about doping, and the need for doping education: a questionnaire survey.
    Shibata K; Ichikawa K; Kurata N
    BMC Res Notes; 2017 Aug; 10(1):396. PubMed ID: 28800770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Bieri A; Kamber M; Sterchi M; Mullis PE
    Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to Develop Intelligence Gathering in Efficient and Practical Anti-Doping Activities.
    Holz M; Robertson J
    Med Sport Sci; 2017; 62():139-152. PubMed ID: 28571033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The fight against doping: international and national efforts as exemplified by the Convention of the Council of Europe and the doping regulations of the Swiss National Association for Sports].
    Kamber M
    Schweiz Z Sportmed; 1990 Sep; 38(2):101-6. PubMed ID: 2218473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspective of pharmacists in Qatar regarding doping and anti-doping in sports.
    Mottram D; Khalifa S; Alemrayat B; Rahhal A; Ahmed A; Stuart M; Awaisu A
    J Sports Med Phys Fitness; 2016 Jun; 56(6):817-24. PubMed ID: 25784399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief History of Anti-Doping.
    Ljungqvist A
    Med Sport Sci; 2017; 62():1-10. PubMed ID: 28571021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the role of national anti-doping organisations in the fight against doping: from past to future.
    Kamber M
    Forensic Sci Int; 2011 Dec; 213(1-3):3-9. PubMed ID: 21835566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harmonization of anti-doping rules in a global context (World Anti-Doping Agency-laboratory accreditation perspective).
    Ivanova V; Miller JH; Rabin O; Squirrell A; Westwood S
    Bioanalysis; 2012 Jul; 4(13):1603-11. PubMed ID: 22831476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doping control, providing whereabouts and the importance of privacy for elite athletes.
    Valkenburg D; de Hon O; van Hilvoorde I
    Int J Drug Policy; 2014 Mar; 25(2):212-8. PubMed ID: 24462318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What the Japan Cycling Federation hopes to accomplish in cooperation with pharmacists in doping and implementing effective anti-doping controls?].
    Sakamoto Y
    Yakugaku Zasshi; 2011; 131(12):1747-9. PubMed ID: 22129870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Why Did the Sports Pharmacists Create the Card Game?].
    Shimizu M
    Yakugaku Zasshi; 2022; 142(2):115-121. PubMed ID: 35110446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New provisions for prevention and fight against doping].
    Boulu RG
    Ann Pharm Fr; 2002 Sep; 60(5):291-5. PubMed ID: 12378136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-doping policy development process in the sports world (1968~1999): focusing on IOC activities and passive response from Korea].
    Hwang ER; Kim TY
    Uisahak; 2014 Aug; 23(2):269-318. PubMed ID: 25223222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.